Patient–Provider Communication About Prostate Cancer Screening and Treatment

New Evidence From the Health Information National Trends Survey

Soumitra S. Bhuyan, Aastha Chandak, Niodita Gupta, Sudhir Isharwal, Chad A LaGrange, Asos Mahmood, Dan Gentry

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The American Urological Association, American Cancer Society, and American College of Physicians recommend that patients and providers make a shared decision with respect to prostate-specific antigen (PSA) testing for prostate cancer (PCa). The goal of this study is to determine the extent of patient–provider communication for PSA testing and treatment of PCa and to examine the patient specific factors associated with this communication. Using recent data from the Health Information National Trends Survey, this study examined the association of patient characteristics with four domains of patient–provider communication regarding PSA test and PCa treatment: (1) expert opinion of PSA test, (2) accuracy of PSA test, (3) side effects of PCa treatment, and (4) treatment need of PCa. The current results suggested low level of communication for PSA testing and treatment of PCa across four domains. Less than 10% of the respondents report having communication about all four domains. Patient characteristics like recent medical check-up, regular healthcare provider, global health status, age group, marital status, race, annual household income, and already having undergone a PSA test are associated with patient–provider communication. There are few discussions about PSA testing and PCa treatment options between healthcare providers and their patients, which limits the shared decision-making process for PCa screening and treatment as recommended by the current best practice guidelines. This study helps identify implications for changes in physician practice to adhere with the PSA screening guidelines.

Original languageEnglish (US)
Pages (from-to)134-146
Number of pages13
JournalAmerican Journal of Men's Health
Volume11
Issue number1
DOIs
StatePublished - Jan 1 2017

Fingerprint

Prostate-Specific Antigen
health information
Early Detection of Cancer
Prostatic Neoplasms
cancer
Communication
communication
Health
trend
evidence
Therapeutics
Practice Guidelines
Health Personnel
physician
Physicians
Surveys and Questionnaires
Marital Status
Expert Testimony
household income
marital status

Keywords

  • Prostate-specific antigen (PSA) testing
  • general health and wellness
  • health communication
  • healthcare issues
  • prostate cancer

ASJC Scopus subject areas

  • Health(social science)
  • Public Health, Environmental and Occupational Health

Cite this

Patient–Provider Communication About Prostate Cancer Screening and Treatment : New Evidence From the Health Information National Trends Survey. / Bhuyan, Soumitra S.; Chandak, Aastha; Gupta, Niodita; Isharwal, Sudhir; LaGrange, Chad A; Mahmood, Asos; Gentry, Dan.

In: American Journal of Men's Health, Vol. 11, No. 1, 01.01.2017, p. 134-146.

Research output: Contribution to journalArticle

Bhuyan, Soumitra S. ; Chandak, Aastha ; Gupta, Niodita ; Isharwal, Sudhir ; LaGrange, Chad A ; Mahmood, Asos ; Gentry, Dan. / Patient–Provider Communication About Prostate Cancer Screening and Treatment : New Evidence From the Health Information National Trends Survey. In: American Journal of Men's Health. 2017 ; Vol. 11, No. 1. pp. 134-146.
@article{03136ab96a0745519c076fd80675900c,
title = "Patient–Provider Communication About Prostate Cancer Screening and Treatment: New Evidence From the Health Information National Trends Survey",
abstract = "The American Urological Association, American Cancer Society, and American College of Physicians recommend that patients and providers make a shared decision with respect to prostate-specific antigen (PSA) testing for prostate cancer (PCa). The goal of this study is to determine the extent of patient–provider communication for PSA testing and treatment of PCa and to examine the patient specific factors associated with this communication. Using recent data from the Health Information National Trends Survey, this study examined the association of patient characteristics with four domains of patient–provider communication regarding PSA test and PCa treatment: (1) expert opinion of PSA test, (2) accuracy of PSA test, (3) side effects of PCa treatment, and (4) treatment need of PCa. The current results suggested low level of communication for PSA testing and treatment of PCa across four domains. Less than 10{\%} of the respondents report having communication about all four domains. Patient characteristics like recent medical check-up, regular healthcare provider, global health status, age group, marital status, race, annual household income, and already having undergone a PSA test are associated with patient–provider communication. There are few discussions about PSA testing and PCa treatment options between healthcare providers and their patients, which limits the shared decision-making process for PCa screening and treatment as recommended by the current best practice guidelines. This study helps identify implications for changes in physician practice to adhere with the PSA screening guidelines.",
keywords = "Prostate-specific antigen (PSA) testing, general health and wellness, health communication, healthcare issues, prostate cancer",
author = "Bhuyan, {Soumitra S.} and Aastha Chandak and Niodita Gupta and Sudhir Isharwal and LaGrange, {Chad A} and Asos Mahmood and Dan Gentry",
year = "2017",
month = "1",
day = "1",
doi = "10.1177/1557988315614082",
language = "English (US)",
volume = "11",
pages = "134--146",
journal = "American Journal of Men's Health",
issn = "1557-9883",
publisher = "SAGE Publications Inc.",
number = "1",

}

TY - JOUR

T1 - Patient–Provider Communication About Prostate Cancer Screening and Treatment

T2 - New Evidence From the Health Information National Trends Survey

AU - Bhuyan, Soumitra S.

AU - Chandak, Aastha

AU - Gupta, Niodita

AU - Isharwal, Sudhir

AU - LaGrange, Chad A

AU - Mahmood, Asos

AU - Gentry, Dan

PY - 2017/1/1

Y1 - 2017/1/1

N2 - The American Urological Association, American Cancer Society, and American College of Physicians recommend that patients and providers make a shared decision with respect to prostate-specific antigen (PSA) testing for prostate cancer (PCa). The goal of this study is to determine the extent of patient–provider communication for PSA testing and treatment of PCa and to examine the patient specific factors associated with this communication. Using recent data from the Health Information National Trends Survey, this study examined the association of patient characteristics with four domains of patient–provider communication regarding PSA test and PCa treatment: (1) expert opinion of PSA test, (2) accuracy of PSA test, (3) side effects of PCa treatment, and (4) treatment need of PCa. The current results suggested low level of communication for PSA testing and treatment of PCa across four domains. Less than 10% of the respondents report having communication about all four domains. Patient characteristics like recent medical check-up, regular healthcare provider, global health status, age group, marital status, race, annual household income, and already having undergone a PSA test are associated with patient–provider communication. There are few discussions about PSA testing and PCa treatment options between healthcare providers and their patients, which limits the shared decision-making process for PCa screening and treatment as recommended by the current best practice guidelines. This study helps identify implications for changes in physician practice to adhere with the PSA screening guidelines.

AB - The American Urological Association, American Cancer Society, and American College of Physicians recommend that patients and providers make a shared decision with respect to prostate-specific antigen (PSA) testing for prostate cancer (PCa). The goal of this study is to determine the extent of patient–provider communication for PSA testing and treatment of PCa and to examine the patient specific factors associated with this communication. Using recent data from the Health Information National Trends Survey, this study examined the association of patient characteristics with four domains of patient–provider communication regarding PSA test and PCa treatment: (1) expert opinion of PSA test, (2) accuracy of PSA test, (3) side effects of PCa treatment, and (4) treatment need of PCa. The current results suggested low level of communication for PSA testing and treatment of PCa across four domains. Less than 10% of the respondents report having communication about all four domains. Patient characteristics like recent medical check-up, regular healthcare provider, global health status, age group, marital status, race, annual household income, and already having undergone a PSA test are associated with patient–provider communication. There are few discussions about PSA testing and PCa treatment options between healthcare providers and their patients, which limits the shared decision-making process for PCa screening and treatment as recommended by the current best practice guidelines. This study helps identify implications for changes in physician practice to adhere with the PSA screening guidelines.

KW - Prostate-specific antigen (PSA) testing

KW - general health and wellness

KW - health communication

KW - healthcare issues

KW - prostate cancer

UR - http://www.scopus.com/inward/record.url?scp=85006427536&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85006427536&partnerID=8YFLogxK

U2 - 10.1177/1557988315614082

DO - 10.1177/1557988315614082

M3 - Article

VL - 11

SP - 134

EP - 146

JO - American Journal of Men's Health

JF - American Journal of Men's Health

SN - 1557-9883

IS - 1

ER -